OTCPK:MIHI

Stock Analysis Report

Medical Innovation Holdings

Executive Summary

Medical Innovation Holdings, Inc. focuses on establishing a multi-disciplinary medical specialist provider/practice network to serve rural patient population through telemedicine program.


Snowflake Analysis

Mediocre balance sheet with weak fundamentals.

Share Price & News

How has Medical Innovation Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MIHI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

MIHI

-4.3%

US Healthcare

-2.7%

US Market


1 Year Return

-63.8%

MIHI

9.3%

US Healthcare

21.2%

US Market

Return vs Industry: MIHI underperformed the US Healthcare industry which returned 14.1% over the past year.

Return vs Market: MIHI underperformed the US Market which returned 24.7% over the past year.


Shareholder returns

MIHIIndustryMarket
7 Day0%-4.3%-2.7%
30 Day22.0%-2.0%0.09%
90 Day-39.0%11.4%6.9%
1 Year-63.8%-63.8%11.1%9.3%23.8%21.2%
3 Year-99.7%-99.7%47.5%40.9%48.1%38.6%
5 Yearn/a62.2%50.9%72.5%53.4%

Price Volatility Vs. Market

How volatile is Medical Innovation Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Medical Innovation Holdings undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Medical Innovation Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Medical Innovation Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of MIHI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Medical Innovation Holdings regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Medical Innovation Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Innovation Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of MIHI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Medical Innovation Holdings's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Medical Innovation Holdings performed over the past 5 years?

13.5%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Medical Innovation Holdings has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Medical Innovation Holdings's financial position?


In this section we usually analyse Medical Innovation Holdings's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Medical Innovation Holdings has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of MIHI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Medical Innovation Holdings's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Medical Innovation Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.4%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate MIHI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MIHI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MIHI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MIHI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MIHI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Medical Innovation Holdings's salary, the management and board of directors tenure and is there insider trading?

0.9yrs

Average management tenure


CEO

Redgie Green (65yo)

0.7yrs

Tenure

0

Mr. Reginald T. Green, also known as Redgie, has been an Interim Chief Executive Officer of Medical Innovation Holdings, Inc. since May 7, 2019. Mr. Green has been the Chief Executive Officer of Momentum B ...


Management Age and Tenure

0.9yrs

Average Tenure

62yo

Average Age

Experienced Management: MIHI's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Age and Tenure

0.9yrs

Average Tenure

62yo

Average Age

Experienced Board: MIHI's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Management Team

  • Kevin Swint

    Chief Operating Officer

    • Tenure: 2.3yrs
  • Ray DeMotte (62yo)

    CFO & Director

    • Tenure: 0.9yrs
  • Redgie Green (65yo)

    Interim CEO & Director

    • Tenure: 0.7yrs
  • Christopher Leggett (58yo)

    Chief Medical Officer


    Board Members

    • Ray DeMotte (62yo)

      CFO & Director

      • Tenure: 0.9yrs
    • Redgie Green (65yo)

      Interim CEO & Director

      • Tenure: 0.7yrs
    • John Stol (54yo)

      Director

      • Tenure: 3.7yrs

    Company Information

    Medical Innovation Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


    Key Information

    • Name: Medical Innovation Holdings, Inc.
    • Ticker: MIHI
    • Exchange: OTCPK
    • Founded:
    • Industry: Managed Health Care
    • Sector: Healthcare
    • Market Cap: US$228.041k
    • Shares outstanding: 45.61m
    • Website: https://medicalinnovationholdings.com

    Location

    • Medical Innovation Holdings, Inc.
    • 5805 State Bridge Road
    • Suite G-328
    • Duluth
    • Georgia
    • 30097
    • United States

    Listings

    TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
    MIHIOTCPK (Pink Sheets LLC)YesCommon StockUSUSDMay 2016

    Biography

    Medical Innovation Holdings, Inc. focuses on establishing a multi-disciplinary medical specialist provider/practice network to serve rural patient population through telemedicine program. Its integrated practice management system provides electronic medical records/electronic health records, patient scheduling, real time insurance verification, billing, video conferencing, and various systems in an end to end technology platform coupled with the components of a telehealth delivery system. The company is based in Duluth, Georgia. 


    Company Analysis and Financial Data Status

    All financial data provided by Standard & Poor's Capital IQ.
    DataLast Updated (UTC time)
    Company Analysis2020/01/28 00:00
    End of Day Share Price2020/01/07 00:00
    Earnings2018/01/31
    Annual Earnings2017/04/30


    Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.